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Abstract
The duck hepatitis A virus (DHAV), a member of the family Picornaviridae, is the major
cause of outbreaks with high mortality rates in young ducklings. It has three distinctive sero-
types and among them, serotypes 1 (DHAV-1) and 3 (DHAV-3) were recognized in China.
To investigate evolutionary and antigenic properties of the major capsid protein VP1 of
these two serotypes, a primary target of neutralizing antibodies, we determined the VP1
coding sequences of 19 DHAV-1 (spanning 2000-2012) and 11 DHAV-3 isolates (spanning
2008-2014) associated with disease outbreaks. By bioinformatics analysis of VP1
sequences of these isolates and other DHAV strains reported previously, we demonstrated
that DHAV-1 viruses evolved into two genetic lineages, while DHAV-3 viruses exhibited
three distinct lineages. The rate of nucleotide substitution for DHAV-1 VP1 genes was esti-
mated to be 5.57 x 10-4 per site per year, which was about one-third times slower than that
for DHAV-3 VP1 genes. The population dynamics analysis showed an upward trend for
infection of DHAV-1 viruses over time with little change observed for DHAV-3 viruses. Anti-
genic study of representative DHAV-1 and DHAV-3 strains covering all observed major line-
ages revealed no detectable changes in viral neutralization properties within the serotype,
despite the lack of cross-neutralization between serotypes 1 and 3 strains. Structural analy-
sis identified VP1 mutations in DHAV-1 and DHAV-3 viruses that underpin the observed
antigenic phenotypes. Results of our experiments described here shall give novel insights
into evolution and antigenicity of duck picornaviruses.
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Introduction
Duck hepatitis A virus (DHAV) belongs to the genus Avihepatovirus in the Picornaviridae fam-
ily. As the only species in its genus, DHAV consists of three distinctive serotypes, designated
DHAV-1, DHAV-2 and DHAV-3 [1]. This group of viruses can cause an acute, contagious,
fatal liver disease of young ducklings (<6 weeks of age) with morbidity and mortality rates
approaching 100% and 80%, respectively [2]. Among the three serotypes, DHAV-1 is the most
widespread and virulent serotype that has the most significant impact on the worldwide poul-
try industry, while DHAV-2 and DHAV-3 have only been reported in the Taiwan and the USA
and the southeastern Asia [3,4]. These two serotypes have recently become prevalent in China,
Taiwan, and Korea [5–9].
In China, DHAV-1 was first isolated in 1980 in a region with a high-density poultry popula-
tion in the northern part of China. The virus then quickly spread throughout all major poultry
production regions of China and it has caused significant clinical problems in local poultry
industry [10]. In 2013, a live attenuated virus vaccine is the only licensed vaccine against
DHAV-1 in China. After implementation of DHAV-1 vaccination, DHAV-1 has become
endemic with approximately 50% of the poultry flocks being infected annually. What triggers
recurrent DHAV-1 outbreaks is unclear. There is little information about genetic and antigenic
variations associated with DHAV-1 since its first recognition in 1980.
DHAV-3 virus was first isolated in China in 1999 [11]. Presently, both DHAV-1 and
DHAV-3 viruses are co-circulating in duck farms in China and existence of both serotypes
makes disease prevention and control more challenging [12,13]. There are no licensed vaccines
available against DHAV-3 serotype.
As with other picornaviruses, DHAV is a single-stranded, positive-sense RNA virus. The
viral genome is about 7.7kb long, packaged by a protein capsid. The capsid consists of four
different structural proteins (VP1-4) and the assembled virion structure has 60 copies of cap-
sid protein; VP1, VP2, and VP3 proteins are exposed on the surface, while VP4 protein is
entirely internal. Structural and antigenic studies have shown that VP1 and to some extent
VP3 or VP2, are the target for neutralizing antibodies [14,15]. Genetic changes in these
regions frequently alter viral antigenic properties, which make viruses escape immunological
recognition by neutralizing antibodies and as a result lead to the failure of picornavirus vac-
cines [16,17].
The major objective of this study was to study molecular evolution and genetic variation
of the major capsid protein VP1 of DHAV-1 viruses circulating in poultry farms in China
over the past 15 years since 2000. We also expanded this study into DHAV-3 viruses that
have emerged as a concern for local poultry industry. Toward this goal, we determined the
full VP1 sequences of 19 DHAV-1 (spanning 2000–2012) and 11 DHAV-3 isolates (spanning
2008–2014) and conducted a detailed genetic analysis including evolutionary rate and popu-
lation dynamics. Our analysis also included additional 20 DHAV-3 strains whose VP1
sequences were reported previously. We focused on the VP1 protein because it is a major
antigen protein that frequently undergoes genetic changes due to the evolutionary pressure
from host immune system and is the principle target of neutralizing antibodies. In addition
to this genetic evolution study, we also employed a cross-neutralization assay coupled with
representative 4 DHAV-1 and 2 DHAV-3 strains and corresponding antisera to address anti-
genic evolution of duck picornaviruses. The potential implications of these experimental
results are discussed.
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Materials and Methods
Ethics Statement
Generation of chicken antisera against different DHV-1 and DHAV-3 viruses was performed
at Shandong Poultry Institute, China, which was approved by the Institutional Animal Care
and Use Committee of Shandong Poultry Institute (approval number 12–014). Experiments
were performed under biosafety level 2+ conditions. Chickens were not sacrificed in this study.
The IACUC protocol also included virus production experiments through SPF chicken embry-
onic eggs. Only invasive procedure used in this experiment was the inoculation of virus into
eggs by an allanotic route. On the day of harvest that occurred by day 15 since the beginning of
egg hatching, all live chicken embryos were euthanized by placing them at 4°C overnight.
These above procedures including the embryo euthanization were discussed in the IACUC
protocol.
All samples were collected from dead ducklings of infected poultry farms located in Shan-
dong, Guangdong, Henan, and Jiangsu provinces. This work was approved by several govern-
ment institutions, which included Shandong animal health and epidemiology center,
Guangdong animal health and epidemiology center, Henan animal health and epidemiology
center, and Jiangsu animal health and epidemiology center. None of these samples were col-
lected from farms involving endangered or protected species.
Virus isolation and RNA extraction
Clinical samples were collected from 19 poultry farms that experienced DHAV-1 disease out-
breaks from 2000 to 2012. Poultry farms are located in four different provinces. This informa-
tion was summarized in Table 1. Similarly, clinical samples were obtained from 11 poultry
farms where infection and shedding of DHAV-3 viruses were documented (Table 2). For these
studies, liver tissues from the diseased ducks were homogenized in sterile phosphate-buffered
Table 1. Summary of DHAV-1 strains used in this study.
Strain name Year of isolation Location Serotype Genotype Genbank No. Reference
1-FS/00 2000 Guangdong, China DHAV-1 A EU395438 From this study
1-YZ/02 2002 Jiangsu, China DHAV-1 A EF427899 From this study
1-CL/03 2003 Shandong, China DHAV-1 A EF427900 From this study
1-JH/04 2004 Shandong, China DHAV-1 A EU395436 From this study
1-ZZ/04 2004 Henan, China DHAV-1 A EU395439 From this study
1-JH/06 2006 Shandong, China DHAV-1 A EU395435 From this study
1-YN/06 2006 Shandong, China DHAV-1 A EU395437 From this study
1-LQ1/08 2008 Shandong, China DHAV-1 A KF826747 From this study
1-LQ2/08 2008 Shandong, China DHAV-1 A KF826748 From this study
1-LQ3/09 2009 Shandong, China DHAV-1 A KF826749 From this study
1-LQ4/09 2009 Shandong, China DHAV-1 A KF826750 From this study
1-LQ5/09 2009 Shandong, China DHAV-1 A KF826751 From this study
1-LQ7/09 2009 Shandong, China DHAV-1 A KF826752 From this study
1-LQ8/09 2009 Shandong, China DHAV-1 A KF826753 From this study
1-DZ/11 2011 Shandong, China DHAV-1 A KF826754 From this study
1-HY/11 2011 Shandong, China DHAV-1 A KF826755 From this study
1-CP/12 2012 Shandong, China DHAV-1 A KF826760 From this study
1-HCZY/12 2012 Henan, China DHAV-1 A KF826761 From this study
1-JNI/12 2012 Shandong, China DHAV-1 A KF826764 From this study
doi:10.1371/journal.pone.0132982.t001
Duck Hepatitis A Viruses
PLOS ONE | DOI:10.1371/journal.pone.0132982 July 14, 2015 3 / 13
saline (PBS, pH 7.2) to form a 20% suspension(w/v). After centrifugation at 8000 x g for 30
min, the supernatants were filtered by 0.2μm-pore-size syringe-driven filters. The filtered sus-
pensions were then inoculated into 11-day-old healthy DHAV antibody-negative duck embry-
onic eggs via allantoic cavity. Embryonic eggs were examined daily, and the allantoic fluids of
dead embryonic eggs were collected following one more passage. The viral RNAs were
extracted from the allantoic fluids with the MiniBEST viral RNA Extraction kit(TaKaRa)
according to manufacture’s instruction.
Virus gene amplification and sequencing
Based on the sequence information of capsid genes of DHAV-1 and DHAV-3, corresponding
sets of primers were designed to amplify and sequence VP1 genes of DHAV isolates. Primer
sequences from 5’ to 3’ direction were CTCGAGGGTGATTCTAACCAGTT (forward primer) and
GCGGCCGCTTCAATTTCCAGATT (reverse primer) for DHAV-1, and CTCGAGGGTGATTC
CAATCAGCT (forward primer) GCGGCCGCTTCAATYTCCARAT (reverse primer) for DHAV-
Table 2. Summary of DHAV-3 strains used in this study.
Strain name Year of isolation Location Serotype Genotype Genbank No Reference
3-G/99 1999 Fujian, China DHAV-3 C EU755009.1 Shi et al., 2009
3-GD/99 1999 Guangdong, China DHAV-3 C GQ122332.1 Yuan et al., 2010
3-MY02/00 2000 Sichuan, China DHAV-3 C KJ461995.1 ncbi.nlm.nih.gov/genbank
3-AP04114/03 2003 Korea DHAV-3 C DQ812093 Kim et al., 2007
3-AP04009/04 2004 Korea DHAV-3 C DQ256133 Kim et al., 2007
3-AP04203/04 2004 Korea DHAV-3 C DQ256134 Kim et al., 2007
3-C-YCZ/05 2005 Beijing, China DHAV-3 C FJ626672.1 ncbi.nlm.nih.gov/genbank
3-C-PSY/06 2006 Beijing, China DHAV-3 C FJ626670.1 ncbi.nlm.nih.gov/genbank
3-GD1/07 2007 Guangdong, China DHAV-3 C EU289393.1 Fan et al., 2011
3-C-YZC/07 2007 Beijing, China DHAV-3 C FJ626673.1 ncbi.nlm.nih.gov/genbank
3-C-GY/07 2007 Guangdong, China DHAV-3 C EU352805.2 Pan et al., 2009
3-B63/08 2008 Beijing, China DHAV-3 C EU747874.1 ncbi.nlm.nih.gov/genbank
3-FS /08 2008 Guangdong, China DHAV-3 C EU877916.1 He et al., 2009
3-C-PJK/09 2009 Sichuan, China DHAV-3 C KC282430.1 ncbi.nlm.nih.gov/genbank
3-NC/09 2009 Viet Nam DHAV-3 C JF925121.1 ncbi.nlm.nih.gov/genbank
3-DN1/09 2009 Viet Nam DHAV-3 C JF925120.1 ncbi.nlm.nih.gov/genbank
3-YT-BX/12 2012 Shandong, China DHAV-3 C KC191694.1 Xu et al., 2013
3-VF-3/12 2012 Shandong, China DHAV-3 C KC191681.1 Xu et al., 2013
3-CH1/12 2012 Shandong, China DHAV-3 C KJ461980.1 ncbi.nlm.nih.gov/genbank
3-HB131216/13 2013 Hubei, China DHAV-3 C KJ461990.1 ncbi.nlm.nih.gov/genbank
3-FX/08 2008 Shandong, China DHAV-3 C KF826745 From this study
3-JS/08 2008 Jiangsu, China DHAV-3 C KF826746 From this study
3-HKY/11 2011 Shandong, China DHAV-3 C KF826756 From this study
3-TA/11 2011 Shandong, China DHAV-3 C KF826757 From this study
3-FH/11 2011 Henan, China DHAV-3 C KF826758 From this study
3-HC/11 2011 Henan, China DHAV-3 C KF826759 From this study
3-JS/12 2012 Jiangsu, China DHAV-3 C KF826762 From this study
3-JM/12 2012 Shandong, China DHAV-3 C KF826763 From this study
3-JNA/13 2013 Shandong, China DHAV-3 C KF826765 From this study
3-/13 2013 Shandong, China DHAV-3 C KF826766 From this study
3-ZP/14 2014 Shandong, China DHAV-3 C KM267028 From this study
doi:10.1371/journal.pone.0132982.t002
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3. The gene sequences (VP1) of 19 DHAV-1 and 11 DHAV-3 viruses were already submitted
to Genbank and their accession numbers were described in Table 1 and Table 2, respectively.
Evolutionary and population genetics analysis
We used VP1 sequence information from our 19 DHAV-1 (spanning 2000–2012) and 11
DHAV-3 isolates (spanning 2008–2014) together with other DHAV isolates reported previ-
ously for this analysis. To estimate evolutionary rate for DHAV-1 and DHAV-3, we first
detected whether there were virus sequences coming from recombination, which could affect
rate estimation [18]. By using cutoff P value of 0.05, no recombination signal was detected
using RDP3[19] for both subtypes. Identical sequences were removed by only keeping the earli-
est one. Then, we estimated the optimal nucleotide substitution model for each subtype using
Mega5 [20]. HKY and HKY+Gamma nucleotide substitution models were then used to calcu-
late divergence distances for DHAV-1 and DHAV-3 respectively. Rate estimation and time
tree construction were then performed using Beast [21]. To find the optimal molecular clock
model for rate estimation, we ran a test simulation for each dataset with ten million steps using
a relaxed molecular clock model and a Bayesian skyline plot tree model. Previous study showed
that if the distribution of coefficient of variation statistic contains a high frequency of zero, a
restrictive molecular clock model should be used [22]. The analyses showed that restrict molec-
ular clock and lognormal relaxed molecular clock models fit subtype 1 and subtype 3 datasets
best respectively [18]. We then tested four coalescent population models (constant population
size, Bayesian skyline plot, exponential population size and extended Bayesian skyline plot) as
tree prior for tree likelihood estimation using path sampling algorithm [23]. Bayesian skyline
plot was predicted to be the optimal model for both datasets. Finally, we ran a MCMC simula-
tion of 107 steps for each dataset and estimated evolutionary rate. Both simulations converged
and the effective sample sizes were greater than 200 for all estimated parameters. Population
size dynamics was analyzed using Tracer [21] with the first 106 steps as burnin. The maximum
clade credibility trees were generated using TreeAnnotator and showed in Figtree [21].
Serum neutralization assay
To generate antisera for serum neutralization assay, we selected five representative DHAV-1
strains circulated between 2000 and 2012 (1-YZ/02, 1-CL/03, 1-FS/00, 1-ZZ/04, 3-FX/08 and
3-HC/11) for antigen preparations. Each antigen containing 104ELD50 of DHAV-1 was inocu-
lated respectively to two 21-day SPF chickens by the intramuscular route. At three weeks after
the inoculation, all animals were boosted with the same dose and route as used in the original
immunization. Bulk blood was collected on 15 days after the second immunization for prepara-
tion of sera. For each antigen, a pool of sera from two animals was used in the serological tests.
Same strategy was used to generate antisera against two DHAV-3 viruses, 3-FX/08 and 3-HC/11.
To determine the cross-reactivity of DHAV-1 and DHAV-3 viruses, the heat-inactivated anti-
sera, two-fold serially diluted, were respectively mixed with 200 ELD50 of each of the five DHAV-
1 and two DHAV-3 strains. After the mixture incubated at 37°C for 1h, they were inoculated into
11-day-old healthy DHAV antibody-free duck embryonic eggs via allantoic cavity. Embryonic
eggs were checked daily, and dead embryos were recorded up to 6 days post-inoculated. The
serum neutralizing titers were determined by the minimal serum dilution that inhibited chicken
embryo death. The titers were the mean values of two repeated experiments.
The antigenic relationship of viruses was determined by the following ratio: neutralizing
antibody titer against the heterologous virus divided by neutralizing antibody titer against the
homologous virus. Differences in the correlation values obtained by the polyclonal antiserum
were evaluated according to standard criteria.
Duck Hepatitis A Viruses
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Secondary structure modeling and comparison of VP1 proteins
The PSIPRED program [24] was used in this study to predict and compare at the secondary
structure level VP1 proteins of DHAV-1 and DHAV-3 viruses, which were used in serum neu-
tralization experiment.
Results and Discussion
Virus isolates and disease outbreaks
To study molecular evolution and genetic variation of the major capsid protein VP1 of DHAV-
1 and DHAV-3 viruses circulated in China over the past decade, we isolated 19 DHAV-1
strains (spanning 2002–2012) and 11 DHAV-3 strains (spanning 2008–2014), each from indi-
vidual farms where disease outbreaks were documented. These poultry farms that derived
DHAV-1 isolates are located in four different provinces (Shandong, Jiangsu, Henan, and
Guangdong) with most farms residing in Shandong (Table 1). Similarly, DHAV-3 viruses were
obtained from these regions with the exception of Guangdong (Table 2). Virus isolates were
derived from infected young ducklings (<6 weeks) with mortality rates reaching approximately
80% (data not shown).
Genetic analysis of the VP1 protein
Viruses grown in duck embryonic eggs were purified and RT-PCR reactions were subsequently
conducted on RNA extractions. The genomic coding sequences for the VP1 proteins of these
DHAV-1 and DHAV-3 viruses were determined and used for genetic and structural analysis in
this study. We first performed ClustalW alignment of the VP1 protein sequences. Our results
showed that more than 94% amino acid sequence homology existed in the VP1 proteins of
intra-serotype strains (DHAV-1 or DHAV-3), while only 76% identity was observed in the
VP1 proteins between DHAV-1 and DHAV-3 (data not shown). Low degree of VP1 protein
sequence homology likely played an integral role in discriminating DHAV viruses into distinc-
tive serotypes.
Phylogenetic and evolutionary rate analysis
We next sought to determine the evolutionary relations of VP1 genes in the context of their
serotypes (DHAV-1 or DHAV-3). We also incorporated VP1 gene sequences of other DHAV
strains reported previously into our analysis. Bayesian phylogenetic tree, divergence time and
substitution rate for the VP1 genes were estimated for the two subtypes separately.
The phylogenetic tree inferred for DHAV-1 viruses shows two main lineages with Bayesian
posterior probability support of 1 (Fig 1). One (indicated in green line) consisted of 16 strains
that circulated from 2000 to 2012; the other (indicated in red line) included 3 strains spanning
2002–2012. The divergence time of the two lineages was traced down to 1960s, which suggests
they evolved separately for a long time. This estimated time seems in a good agreement with an
earliest report in 1953 that described the isolation of the first DHAV-1 virus. Because DHAV-1
was first isolated in 1980 in China, it is possible that the two lineages were brought to China
separately. To further investigate whether the two lineages come from geographically isolated
populations in China, we compared their geographic distributions. Probably due to the result
of rapid movement of ducklings in modern poultry industry, we noticed that strains from one
lineage were geographically found in place where viruses of another lineage observed. Because
current analysis contains a limited number of virus strains, further exploration of DHAV-1
evolution with more strains is required.
Duck Hepatitis A Viruses
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The VP1 phylogenetic tree of DHAV-3 viruses divided this group of viruses into two major
lineages with Bayesian posterior probability support of 1 (Fig 2). One lineage consisted of most
of our isolated strains (indicated in light yellow or blue line) covering the disease outbreaks
from 1999 to 2014. It is intriguing to note that this lineage was likely further split into two sub-
lineages (indicated in light yellow and blue lines respectively) with Bayesian posterior probabil-
ity support of 0.99. The other lineage (indicated in pink line) contained only 6 members span-
ning 2003–2009. Nevertheless, additional analysis of this lineage showed that all these strains
were isolated from Korea (3-AP04114/03, 3-AP04009/04, and 3-AP04023/04) and Viet Nam
(3-NC/09 and 3-DN1/09) with the exception of 3-B63/08, which was isolated from a poultry
farm in Beijing, China. It is likely that this lineage originated in Korea and was subsequently
spread to China and Viet Nam. As such, geographical evidence for establishment of this lineage
is obvious. Challenge for collecting geographical evidence in support for the presence of the
Fig 1. Bayesian MaximumClade credibility tree of VP1 gene of DHAV-1 virus inferred using Beast program. The two lineages with probability support
of 1 were colored green and red respectively. The probabilities of the most internal nodes were shown. The inferred divergence time was shown below the
tree. The black bar represents 95% high probability interval for the most recent common ancestor. Virus strains were named in the order of serotype,
abbreviations of isolation place and two digits isolation time. See materials section and Table 1 for abbreviations of isolates and their locations.
doi:10.1371/journal.pone.0132982.g001
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other DHAV-3 lineage and two DHAV-1 lineages may be due to increased industrialization of
poultry farm operation and rapid movement of ducklings within China.
We also estimated the evolutionary rates of VP1 genes of DHAV-1 and DHAV-3 viruses.
Our data indicated that the estimated substitution rate for DHAV-1 and DHAV-3 viruses was
about 5.57 × 10-4 (95% high probability density interval: 2.66x10-4 -8.45x10-4) and 1.90 × 10-3
(95% high probability density interval: 1.3x10-3 -2.6x10-3) nucleotides per site per year, respec-
tively. It seemed that DHAV-3 viruses evolved about three times faster than that of DHAV-1
and is comparable to the generalized evolutionary rate of Influenza A virus [25]. The high evo-
lutionary rate of DHAV-3 viruses may facilitate the emergence of new variants, which may
warrant a regular surveillance in the field.
Fig 2. Bayesian MaximumClade credibility tree of VP1 gene of DHAV-3 virus. The orange and blue colored branches represent one lineage while pink
colored branches represents the other lineage. The probabilities of the most internal nodes were shown. The inferred divergence time was shown below the
tree. The black bar represents 95% high probability interval for the most recent common ancestor. Virus strains were named in the order of serotype,
abbreviations of isolation place and two digits isolation time. See materials section and Table 1 for abbreviations of isolates and their locations.
doi:10.1371/journal.pone.0132982.g002
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Population dynamics analysis
Effective population size is usually used for studying longitudinal virus expansions over time
that have been best studied in HIV[26]. We employed this analytic tool to study DHAV-1 and
DHAV-3 viruses.
From the population dynamics plots showed in Fig 3, we observed a trend of increased
infection of ducks by DHAV-1 in recent years (Fig 3A). Interestingly, there was no noticeable
change in population size of DHAV-3 infection (Fig 3B), despite a little reduction in DHAV-3
viruses-associated infection landscape at 2009. It is possible that there was an evolution bottle-
neck around 2009 and DHAV-3 viruses may escape later by some key mutations.
Fig 3. Effective population dynamics of DHAV-1 and DHAV-3 viruses. (A) Population dynamics of
DHAV-1 viruses from 2000 to 2012. (B) Population dynamics of DHAV-3 viruses from 1999 to 2014. The
estimated mean population size is shown using black line. At each time point, the blue colored region
represents 95% high confidence intervals of population size. Because the generation time virus is unclear,
the population size here is the product of effective population size and virus generation time. We assumed
virus generation time is constant during evolution for our inference.
doi:10.1371/journal.pone.0132982.g003
Duck Hepatitis A Viruses
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Serological characterization of the DHAV-1 and DHAV-3 viruses
The intra- and inter-serotype cross-reactivity of DHAV-1 and DHAV-3 viruses representing
all major lineages or sub-lineages was measured by serum neutralization. Four sub-lineage-
representative viruses and corresponding antisera for DHAV-1 (1-FS/00, 1-YZ/02, 1-CL/03,
and 1-ZZ/04) and two sub-lineage-representative viruses and corresponding antisera for
DHAV-3 (3-FX/08 and 3-HC/11) were used in this experiment. We also included a live-atten-
uated DHAV-1 vaccine (1-AV2111) and its antiserum in our study and this vaccine is cur-
rently in use against DHAV-1 infection of ducklings in China. The primary goal was to address
the influence of genetic diversity on antigenic variation of these circulated viruses, especially
those within the same serotype as determined in sequence analysis.
As summarized in Tables 3 and 4, five DHAV-1 viruses exhibited no detectable cross-reac-
tivity (<10) with two DHAV-3 antisera. Similarly, two DHAV-3 viruses were insensitive to
neutralization by five DHAV-1 antisera. The high cross-reactivity observed between intra-sero-
type viruses (DHAV-1 or DHAV-3) suggested that the observed genetic variations in VP1 over
the past fourteen years for DHAV-1 or over the past six years for DHAV-3 had no effects on
neutralizing properties of these viruses. We also observed that DHAV-1 vaccine-derived anti-
serum was capable of neutralizing all these tested DHAV-1 viruses (Table 3) and this result
indicated that the DHAV-1 vaccine currently in market is protective against infection of
Table 3. Neutralization index among Different DHAV Strains.
Strains Antisera
1-YZ/02* 1-CL/03* 1-FS/00* 1-ZZ/04* AV2111* 3-FX/08* 3-HC/11*
1-YZ/02** 186 240 115 66 112 <10 <10
1-CL/03** 191 282 127 81 135 <10 <10
1-FS/00** 181 238 114 73 112 <10 <10
1-ZZ/04** 141 151 107 69 110 <10 <10
AV2111** 120 135 103 60 102 <10 <10
3-FX/08** <10 <10 <10 <10 <10 158 112




Table 4. Correlations Rates of Neutralization Assays testing DHAV-1 and DHAV-3 strains.
Strains Antisera
1-YZ/02* 1-CL/03* 1-FS/00* 1-ZZ/04* 1-AV2111* 3-FX/08* 3-HC/11*
1-YZ/02** 1.00
1-CL/03** 0.93 1.00
1-FS/00** 0.99 0.97 1.00
1-ZZ/04** 0.90 0.80 0.99 1.00
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ducklings by DHAV-1 viruses. Intriguingly, vaccine efficacy against DHAV-1 extrapolated
from our serum neutralization data seemed to be in discordance with the increased population
size of DHAV-1 infection over time in ducks as we estimated (Fig 3A). Several factors such as
vaccination regime and coverage of duck population probably conducted in the field as a whole
may cause this disagreement. This speculation was also supported by periodic outbreaks of
DHAV-1 in recent years despite the implementation of DHAV-1 vaccination.
Amino Acid Variability of the VP1 protein
The extremely low homology (less than 20%) of DHAV VP1 protein with its counterparts in
other picornaviruses whose three-dimensional structures were resolved prevented us from con-
ducting a structural modeling analysis. In this regard, we predicted the second structure of the
VP1 protein and used it as a template for primary amino acid sequence alignment for VP1 pro-
teins of DHAV-1 and DHAV-3 viruses analyzed in serum neutralization assay (Table 3). Our
primary focus was to identify amino acid variations in the VP1 protein that discriminated
viruses into serotypes 1 and 3 respectively. We used DHAV-1 strain 1-CL/03 as a reference
strain to develop a secondary structure model of the VP1 protein and employed it for further
analysis. Considering that DHAV-1 and DHAV-3 viruses shared 76% homology in their VP1
protein, we reasoned that the VP1 model derived from DHAV-1 should be applicable to struc-
tural analysis for the VP1 protein of DHAV-3 strains.
Secondary structure analysis revealed that VP1 protein of duck picornaviruses structurally
consisted of seven α-helices, fourteen ß–sheets, and twenty linker regions (Fig 4). Despite that
amino acid variations between DHAV-1 and DHAV-3 were found across the whole VP1 pro-
tein except for positions 1–47, substitutions between these two serotypes seemed to occur
largely in the middle (positions 138–146) and C-terminal portions (positions 178–199 and
212–219) of the VP1 protein. These naturally occurring changes are probably responsible for
the distinct antigenicity observed between DHAV-1 and DHAV-3. In addition, total thirteen
substitutions occurred in VP1 proteins of three DHAV-1 viruses relative to the DHAV-1
Fig 4. Sequence alignment and predicted secondary structure of VP1 protein of DHAV-1 and DHVA-3 viruses.Orange arrows are β strands while
green rectangles are α helices. DHAV-1 strain 1-CL/03 is used here as a reference strain for development of a secondary structure model of VP1.
doi:10.1371/journal.pone.0132982.g004
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reference strain 1-CL/03 (Fig 4). These changes located at eleven sites across the VP1 protein
(positions 43, 54, 108, 112, 179, 180, 182, 183, 186, 192, and 211). These VP1 polymorphisms
apparently had no effect on neutralizing properties of viruses within the serotype 1 of duck
hepatitis A virus.
In conclusion, this study presents for the first time in-depth analysis of DHAV-1 and
DHAV-3 viruses with a focus on VP1 gene, one of most diverse genes in the family Picornaviri-
dae. Our data showed that DHAV-1 viruses are both genetically and antigenically stable over a
period of the past fourteen years. Interestingly, we found that DHAV-3 viruses evolved slightly
faster than DHAV-1 viruses but the increased evolutionary rate resulted in no antigenic change
within this serotype. Both intra- and inter-serotype mutations identified in the VP1 protein
shall provide important guidance for regular surveillance of DHAV field strains toward the
identification of potential genetic mutations that may render viruses escape pre-existing immu-
nity and cause new epidemics.
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